Sen. Grassley Letter to Harvard: Biederman Research Protocol Breaches
The most shocking disclosure is that Dr. Biederman’s study testing powerful antipsychotics in PRESCHOOL CHILDREN "was beset by breaches of research protocol,"
The most shocking disclosure is that Dr. Biederman’s study testing powerful antipsychotics in PRESCHOOL CHILDREN "was beset by breaches of research protocol,"
The most shocking disclosure: a Biederman study testing the use of powerful antipsychotics in PRESCHOOL CHILDREN "was beset by breaches of research protocol."
A series of slides, all prepared by Dr. Biederman–according to his sworn testimony–are revealing as they raise serious doubts about the scientific and ethical integrity of his oeuvre.
The unsealed documents reveal that AstraZeneca “buried” unfavorable studies that showed Seroquel posed a serious risk for diabetes.
“Current users of typical and of atypical antipsychotic drugs had higher rates of sudden cardiac death than did nonusers of antipsychotic drugs.” NEJM 2009
"Whatever powers the Constitution has granted our government, involuntary mind control is not one of them, absent extraordinary circumstances." 1979, Judge Joseph L. Tauro
A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing division-provide a bird’s eye view of collusion between the drug giant and Harvard’s leading child psychiatrist, Dr. Joseph Biederman, and one of Harvard’s premier teaching hospitals, Massachusetts General Hospital.
"The committee’s concerns are part of a growing chorus of complaints about the increasing use of antipsychotic medicines in children and teenagers.
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels.
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.
Overshadowing all other health related news, a front page report in The Washington Post and the just released Breckenridge report evaluating FDA's abysmal performance on drug safety, http://ahrp.blogspot.com/2007/03/latest-report-blasts-fda-bungling-drug.html require Congressional action.
This young child represents millions of children in the United States who are falling prey to licensed, but irresponsible prescribers of toxic drugs.